Skip to main content

Table 4 Quality of life score according to the Marital Status, Sexual Partner, and Sexual Debut of the CC patients

From: Quality of life among cervical cancer patients following completion of chemoradiotherapy at Ocean Road Cancer Institute (ORCI) in Tanzania

QLQ Items

Marital Status

P

Sexual Partner

P

Sexual Debut (years)

P

Married

Single

With

Without

 < 12

 > 13

n = 182

n = 141

n = 160

n = 163

n = 10

n = 313

QLQ-C30 Functional scales

Global Health Status/QOL

63.8 ± 17.6

65.2 ± 17.8

0.284

60.5 ± 16.1

68.5 ± 18.1

0.000

62.5 ± 13.7

64.5 ± 17.8

0.896

Physical Functioning

85.2 ± 14.5

86.5 ± 14.7

0.243

85.0 ± 14.6

86.7 ± 14.6

0.122

82.0 ± 14.1

85.9 ± 14.6

0.282

Role Functioning

90.2 ± 18.3

90.1 ± 18.6

0.936

90.1 ± 18.6

90.1 ± 18.3

0.916

88.3 ± 13.7

90.2 ± 18.5

0.273

Emotional Functioning

79.6 ± 22.9

81.3 ± 22.6

0.942

78.2 ± 24.2

82.8 ± 20.8

0.132

85.8 ± 18.9

80.1 ± 22.8

0.525

Cognitive Functioning

80.7 ± 25.2

82.4 ± 22.2

0.512

78.5 ± 25.5

84.4 ± 21.9

0.085

88.3 ± 13.7

81.2 ± 24.1

0.616

Social Functioning

71.6 ± 30.9

80.1 ± 29.1

0.020

68.2 ± 31.7

83.1 ± 26.5

0.000

86.7 ± 21.9

75.0 ± 30.6

0.340

QLQ-C30 Symptom scales

Fatigue

16.1 ± 18.4

16.2 ± 19.4

0.887

16.3 ± 19.1

15.9 ± 18.5

0.877

8.3 ± 21.2

5.0 ± 15.0

0.623

Nausea & Vomiting

4.3 ± 12.8

6.1 ± 17.8

0.495

4.6 ± 13.7

5.6 ± 16.6

0.840

16.7 ± 13.6

19.9 ± 23.1

0.941

Pain

20.3 ± 22.9

19.1 ± 23.0

0.633

20.1 ± 22.5

19.2 ± 22.9

0.587

6.7 ± 14.1

3.9 ± 14.2

0.238

Dyspnea

2.2 ± 9.0

6.4 ± 18.7

0.030

2.1 ± 9.7

5.8 ± 17.3

0.018

23.3 ± 31.6

12.6 ± 25.0

0.089

Insomnia

11.5 ± 23.1

14.7 ± 27.7

0.433

11.0 ± 22.7

14.9 ± 27.6

0.296

6.7 ± 14.1

9.0 ± 21.9

0.955

Appetite Loss

7.6 ± 18.5

10.7 ± 25.1

0.510

8.0 ± 18.9

10.0 ± 24.2

0.884

23.3 ± 31.6

18.8 ± 27.4

0.700

Constipation

20.1 ± 27.3

17.5 ± 27.8

0.256

21.5 ± 26.5

16.6 ± 28.4

0.014

6.7 ± 21.1

3.7 ± 15.7

0.665

Diarrhea

2.9 ± 14.1

5.0 ± 17.8

0.137

2.3 ± 11.9

5.4 ± 19.0

0.078

36.7 ± 36.7

64.5 ± 36.3

0.020

Financial difficulties

65.4 ± 37.5

61.5 ± 35.5

0.297

66.7 ± 35.9

60.5 ± 37.3

0.205

8.3 ± 21.2

5.0 ± 15.0

0.623

QLQ-CX24 Symptom scales

Symptom Experience

14.0 ± 11.2

14.3 ± 11.9

0.867

14.6 ± 11.7

13.5 ± 11.2

0.492

13.6 ± 9.9

14.1 ± 11.5

0.897

Body Image

23.3 ± 27.3

15.1 ± 24.6

0.003

26.8 ± 28.6

12.0 ± 21.1

0.000

4.4 ± 10.7

20.1 ± 26.6

0.060

Sexual/Vaginal Functioning

30.4 ± 21.9

23.1 ± 23.5

0.307

28.6 ± 18.5

36.1 ± 40.2

0.891

41.7 ± 52

29.0 ± 20.5

0.966

Lymphoedema

7.2 ± 17.1

8.5 ± 18.4

0.552

6.5 ± 16.2

9.1 ± 19.0

0.169

0 ± 0

8.0 ± 17.9

0.118

Peripheral Neuropathy

20.1 ± 28.3

26.2 ± 29.3

0.035

20.6 ± 28.3

25.2 ± 29.4

0.126

40 ± 26.3

22.2 ± 28.8

0.024

Menopausal Symptoms

17.5 ± 31.4

17.0 ± 29.2

0.883

16.3 ± 30.2

18.4 ± 30.7

0.458

23.3 ± 38.7

17.1 ± 30.1

0.751

Sexual Worry

52.8 ± 42.7

36.4 ± 43.3

0.001

54.6 ± 41.6

36.6 ± 43.8

0.000

26.7 ± 37.8

46.2 ± 43.7

0.156

QLQ-CX24 Functional scales

Sexual Activity

14.3 ± 21.7

2.6 ± 12.0

0.000

16.5 ± 22.5

2.1 ± 11.0

0.000

13.3 ± 23.3

9.0 ± 18.9

0.488

Sexual Enjoyment

44.4 ± 29.3

38.1 ± 40.5

0.605

44.4 ± 29.3

38.1 ± 40.5

0.605

77.8 ± 38.5

42.3 ± 29.3

0.084

  1. Values are in mean score ± SD. Significance P < 0.005 by Mann Whitney U test and significant values are bolded